Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators

Biometrika

Volumn 84, Issue 1, 1997, Pages 45-56

  Day, Roger ^a   Bryant, John ^a   Lefkopoulou, Myrto ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Counting process; Frailty model; Landmark analysis; Prediction; Prognosis; Tumour marker

Indexed keywords

EID: 0347472470     PISSN: 00063444     EISSN: None     Source Type: Journal    
DOI: 10.1093/biomet/84.1.45     Document Type: Article

References (13)

1. ANDERSON, J. R., CAIN, K. C. & GELBER, R. D. (1983). Analysis of survival by tumor response category. J. Clin. Oncol. 1, 710-9.
2. CARTER, G. E., LIESKOVSKY, G., SKINNER, D. G. & PETROVICH, Z. (1989). Results of local and/or systemic adjuvant therapy in the management of pathological stage C of D1 prostate cancer following radical prostatectomy. J. Urol. 142, 1266-71.
3. CHOI, S., LAGAKOS, S. W., SCHOOLEY, R. T. & VOLBERDING, P. A. (1993). CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann. Internal Med. 118, 674-80.
4. CLAYTON, D. (1978). A model for the association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65, 141-51.
5. CLAYTON, D. & CUZICK, J. (1985). Multivariate generalizations of the proportional hazards model. J. R. Statist. Soc. A 148, 82-117.
6. CUZICK, J. (1982). Rank tests for association with right censored data. Biometrika 69, 351-64.
7. FLEMING, T. R. & HARRINGTON, D. P. (1991). Counting Processes & Survival Analysis. New York: Wiley.
8. GAIL, M. (1981). Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 37, 67-78.
9. GRAVERSEN, P. H., NIELSEN, K. T., GASSER, T. C., CORLE, D. K. & MADSEN, P. O. (1990). Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer: a fifteen-year follow-up. Urology 36, 493-8.
10. GREGORY, W. M., RICHARDS, M. A., SLEVIN, M. L. & SOUHAMI, R. L. (1991). A mathematical model relating response durations to amount of subclinical resistant disease. Cancer Res. 51, 1210-6.
11. OAKES, D. (1982). A model for association in bivariate survival data. J. R. Statist. Soc. B 44, 414-22.
12. OAKES, D. (1989). Bivariate survival models induced by frailties. J. Am. Statist. Assoc. 84, 487-93.
13. WEISS, G. B., BUNCE, H. & HOKANSON, J. A. (1983). Comparing survival of responders and non-responders after treatment: a potential source of confusion in interpreting cancer clinical trials. Control. Clin. Trials 4, 43-52.